High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Shares of Coherent Corp. (NYSE:COHR) are up 59% year to date (YTD) in 2026, a striking run for a stock leveraged to the shift from copper to optical connectivity inside AI data centers. Coherent stock trades at $294.37, and the gain looks substantial in isolation. Yet, the same optical-components trade that lifted Coherent lifted its […]
Critical Metals (NASDAQ:CRML) stock trades at $8.39, up 9% in Thursday afternoon trading. The move stands out because the rare earth complex around Critical Metals has drifted lower into midweek, leaving one name doing the work the group used to share. MP Materials (NYSE:MP) stock is at $49.37, rising 1% on the session. USA Rare […]
Quantum computing stocks are extending their recent rebound Thursday as investors continue to digest a series of technical developments across the industry. IonQ (NYSE:IONQ) stock is up 4% to $44.08, while D-Wave Quantum (NYSE:QBTS) stock is gaining 3% to $17.23 and Rigetti Computing (NASDAQ:RGTI) stock is adding 2% to $16.28. The gains come as the […]
A JPMorgan upgrade and surging compute prices should lift all AI infrastructure boats, yet Nebius, CoreWeave, and IREN are heading in three completely different directions Thursday, and the reason why reveals something important about where real pricing power actually lives.
Vanguard seeds every eligible child's Trump Account with $1,500 starting in 2027, but the obvious fund choice quietly costs more than it needs to over 18 years of compounding. The ticker most parents will pick first is the wrong one for this account.
Jaguar Health and Viking Therapeutics are both sinking Wednesday morning, but the forces behind each drop point in completely different directions, and the broader biotech sector is barely flinching.
IonQ just dropped two back-to-back announcements that sent its stock surging while the broader quantum ETF slipped, and the reason one company is pulling so far away from the pack reveals something important about where the real quantum race is being run.
Buying into an all-time high at 66 feels like the worst possible timing, but the data on what actually happens next might change how you think about that cash sitting on the sidelines.
Momentum in radio frequency chips has a clear name this month. Skyworks Solutions (NASDAQ:SWKS) stock has been the standout story, running past its merger partner, its larger listed peer, and the broader semiconductor complex on the way up. That kind of move, in a name that spent much of the prior year drifting, raises a […]
Shares of Bloom Energy (NYSE:BE) have gone on a month-long tear that stands out against both the broad market and every other name in its immediate neighborhood. Bloom Energy stock is at $277.81, having gained 38% over the past month, a run big enough to make the take-profits-or-buy-more question the one worth asking on this […]
Cleveland-Cliffs is surging well past its steel peers on Tuesday with no confirmed catalyst behind the move, and the gap between its year-to-date performance and Nucor's tells a story about where the next trade could be hiding.
AutoZone's latest quarter split the market in two directions at once, and the ripple through its rivals says something surprising about how traders are reading the aftermarket retail group right now.
Rosenblatt's initiation on SanDisk sent shares surging and lit up the entire memory sector Tuesday, but the analyst's own warning buried inside the note raises a real question about how long this rally can last.
On Holding just did something it has never done before, and the stock is repricing fast. Whether today's surge marks a turning point or a trap depends on what management actually promised investors in Zurich.
Alibaba just unveiled a chip it claims reshapes the AI compute landscape inside China, and the stock is reacting sharply, but one key rival is barely moving, and that gap reveals exactly who the market thinks wins here.
Coretura just handed BlackBerry its first named design win for Alloy Kore, sending shares surging well past the broader software sector, but the deal comes with no contract value, no revenue timeline, and an earnings report less than 48 hours away.
Ryan Cohen just bought another million-plus shares of GameStop at a higher price than his purchase two weeks ago, yet the stock is barely moving. That gap between what the CEO is signaling and how the market is responding tells a complicated story about where GameStop goes from here.
AMC's latest debt move shifts a key deadline further into the future, but whether that buys the struggling theater chain genuine breathing room or simply delays a reckoning depends on details the market is still pricing in.
A Cramer lightning-round call just sent BlackBerry shares surging ahead of a quarterly report that could either validate the QNX software story or unwind the entire move in a single session.
A coveted Presidential Symposium slot at Europe's top oncology congress just sent Moderna shares flying 9%, but the actual Phase 3 melanoma data remains unseen. Here is why the scheduling alone is moving markets and what it signals about what that dataset might show.
Cantor Fitzgerald just restated its bull case for Rocket Lab with a $122 target, yet the stock is trailing a space peer that received no catalyst at all, and that disconnect tells you something important about what is actually driving Monday's rally.
Antitrust settlement talks are reshuffling the media landscape in real time, sending two rival stocks surging for completely opposite reasons while their biggest streaming competitor barely flinches.
Bitcoin just hit its highest level since January, and the equity complex is repricing fast but not evenly. Understanding why Strategy is outrunning the miners it resembles tells you everything about how these trades actually work.
A U.S.-Greenland security pact sent one small-cap rare earth stock soaring 25% at the open, but the deal contains a catch that changes nothing about what the company actually owns or produces.
Novo Nordisk (NVO) will hold its 2026 Capital Markets Day in London on Monday.
Both options are rooted in the same basic buy-and-hold philosophy, but one differs from the other in one way that's very important for the foreseeable future.
A simple momentum screen applied to S&P 500 stocks has quietly built a performance gap that turns identical starting portfolios into dramatically different ending balances, and the strategy costs almost nothing to implement.
The buying in artificial intelligence (AI) buildout names on Friday afternoon has a picky shape. Wolfspeed (NYSE:WOLF) is running hard while the group it usually trades with barely moves. IREN Limited (NASDAQ:IREN) is running too, and the pair look more like two separate single-name bids than a coordinated sector trade. The Global X Data Center […]
The stock market aced two big tests this week. Things got weird when CNBC’s Steve Liesman asked Warsh where the federal-funds rate is relative to the so-called neutral rate—the policy rate that is neither accommodative nor restrictive.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
